Active Pharmaceutical Ingredient Contract Manufacturer

Conduct Research

• Handling Highly Active Ingredients
  that offered containment levels between those of gloveboxes and those of cleanrooms, at costs approaching those of cleanrooms. The term for the equipment was questionable at best, since barriers and isolators do. Containment: Handling Highly Active Ingredients | Engineering & Processing | Pharmaceutical...
• Handling Highly Active Ingredients
  operation to the next, and, most interestingly, through flexible-film mini-enclosures that minimize cleaning and related validation. System designs reflect increased a focus on meeting occupational exposure. Containment: Handling Highly Active Ingredients | Engineering & Processing | Pharmaceutical...
• Handling Highly Active Ingredients
  Durney, director for new business development at ILC Dover (Frederica, Del.), claims the cost savings from disposable PPE alone more than offsets the. Containment: Handling Highly Active Ingredients | Engineering & Processing | Pharmaceutical Manufacturing. Digital Magazine: Read / Subscribe. RSS...
• Inside USP s New Pharmaceutical Ingredient Verification Program
  and consistency of these ingredients, U.S. Pharmacopeia (USP) has launched a third-party verification program for active pharmaceutical ingredients (API) and excipients. The program is designed to assure manufacturers, regulatory authorities and consumers that drug substances and excipients bearing...
• Contract Research Drives China's Pharma Sector
  that growth will be CROs. This article will examine the growth of CROs in China, and point out emerging trends in the nation s CRO sector. Since the early 1990s, more and more Chinese Contract Manufacturing Organizations (CMOs) have engaged in Active Pharmaceutical Ingredient (API) production, and many...
• IFPAC Conference Highlights Pharmaceutical Applications of PAT
  . Laurie St. Pierre Berry, PAT specialist at Pfizer's Groton, Conn., plant described her company's use of NIR as well as infrared (IR) and reduction-oxidation techniques. "New PAT strategies are being implemented into API [active pharmaceutical ingredient] facilities for controlling and monitoring...
• Getting the Most from Coriolis Flowmeters in Pharmaceutical Processes
  performance and repeatability. Formulation There are also some opportunities for flow measurement devices during pharmaceutical formulation, which is characterized by smaller-scale handling of the Active Pharmaceutical Ingredient (API) and/or other ingredients. Handling of the Pure API Once...
• Introducing PAT, Using NIR Analysis, to a Pharmaceutical Blending Process
  determination involve sampling of the blend using a sample thief and laboratory analysis of the samples using chemical methods . In addition, blend uniformity in the traditional sense focuses on the distribution of the active pharmaceutical ingredient in the blend as opposed to distribution...
• Risk Management Still Eludes Vaccine Manufacturers
  a major challenge. Vaccines are so unlike traditional medicines: they have no true “active ingredient;” in many cases, it’s not even clear exactly how they work. They remain, defiantly, un-PAT-able. Their production is extremely complex and risk-filled, yet primitive — and their manufacturers...
• Introducing PAT, Using NIR Analysis, to a Pharmaceutical Blending Process
  uniformity in the “traditional sense” focuses on the distribution of the active pharmaceutical ingredient in the blend as opposed to distribution of the excipients in the blend, which can influence the desired performance of the pharmaceutical product2.Magnesium stearate is a commonly used tablet...

Engineering Web Search: Active Pharmaceutical Ingredient Contract Manufacturer